首页|Peking Union Medical College Reports Findings in Surgical Technology (Robot-assi sted Radical Prostatectomy with the KangDuo Surgical System Versus the da Vinci Si System: A Prospective, Double-center, Randomized Controlled Trial)
Peking Union Medical College Reports Findings in Surgical Technology (Robot-assi sted Radical Prostatectomy with the KangDuo Surgical System Versus the da Vinci Si System: A Prospective, Double-center, Randomized Controlled Trial)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Surgery-Surgical Tec hnology is the subject of a report. According to news reporting from Beijing, Pe ople's Republic of China, by NewsRx journalists, research stated, "The KangDuo S urgical Robot (KD-SR) is a newly developed surgical robot. To compare the safety and efficacy of robot-assisted radical prostatectomy (RARP) using the KD-SR wit h those of the da Vinci Si Surgical System (DV-SS-Si)." The news correspondents obtained a quote from the research from Peking Union Med ical College, "A prospective double-center noninferiority randomized controlled trial was conducted among 18-75-yr-old patients with suspected T1-2N0M0 prostate cancer (PCa) scheduled for RARP. RARP with the KD-SR (KD-RARP) versus RARP with the DV-SS-Si (DV-RARP). The primary outcome was surgical success, defined as fo llows: surgery can be performed according to the established protocol, without s witching to other surgical modalities, and without secondary surgery due to surg ical complications after surgery. The secondary outcome was short-term functiona l and oncological outcomes. The noninferiority threshold was set at 10% . Eighty patients were enrolled, while the full analysis set finally included 79 patients (40 with KD-RARP and 39 with DV-RARP). The success rate was 100% in both groups. We could not find differences in urinary continence rate at 1, 2 , 3, and 4 wk after catheter removal between the groups (p > 0.05). The rate of Clavien-Dindo grade II adverse events was 20% in the KD-RARP group and 17.9 % in the DV-RARP group (p = 0.82), an d no grade III adverse events occurred. The median operation time was significan tly longer in the KD-RARP group than in the DV-RARP group (177.5 vs 145 min, p = 0.012). The main limitations were the short follow-up period and that survival was not considered as the primary outcome. The KD-SR is a viable option for RARP , with acceptable short-term outcomes compared with the DV-SS-Si for T1-2 PCa."
BeijingPeople's Republic of ChinaAsi aClinical ResearchClinical Trials and StudiesEmerging TechnologiesHealth and MedicineMachine LearningMale Urologic Surgical ProceduresMedical Devi cesMen's HealthProstatectomyRobotRoboticsSurgerySurgical SystemSur gical Technology
NETL
NSTL
